These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 1829956

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 5 alpha-androstane-3 alpha, 17 beta-diol and 5 alpha-androstane-3 alpha, 17 beta-diol-glucuronide in plasma of normal children, adults and patients with idiopathic hirsutism: a mass spectrometric study.
    Wudy SA, Wachter UA, Homoki J, Teller WM.
    Eur J Endocrinol; 1996 Jan; 134(1):87-92. PubMed ID: 8590963
    [Abstract] [Full Text] [Related]

  • 3. Androstanediolglucuronide: a parameter for peripheral androgen activity before and during therapy with cyproterone acetate.
    Ponjee GA, de Rooy HA, Vader HL.
    Acta Endocrinol (Copenh); 1991 Apr; 124(4):411-6. PubMed ID: 1827701
    [Abstract] [Full Text] [Related]

  • 4. Androstanediol glucuronide plasma clearance and production rates in normal and hirsute women.
    Greep N, Hoopes M, Horton R.
    J Clin Endocrinol Metab; 1986 Jan; 62(1):22-7. PubMed ID: 3940268
    [Abstract] [Full Text] [Related]

  • 5. Physiopathology of plasma androstanediol-glucuronide.
    Vermeulen A, Giagulli VA.
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):829-33. PubMed ID: 1835405
    [Abstract] [Full Text] [Related]

  • 6. Androgen sulfate and glucuronide conjugates in nonhirsute and hirsute women with polycystic ovarian syndrome.
    Matteri RK, Stanczyk FZ, Gentzschein EE, Delgado C, Lobo RA.
    Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1704-9. PubMed ID: 2532471
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
    Frölich M, Lachinsky N, Moolenaar AJ.
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
    [Abstract] [Full Text] [Related]

  • 9. Increased free testosterone but normal 5 alpha-reduced testosterone metabolites in obese premenopausal women.
    Giagulli VA, De Pergola G, Giorgino F, Cignarelli M, Abbaticchio G, Vermeulen A, Giorgino R.
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):553-8. PubMed ID: 1424180
    [Abstract] [Full Text] [Related]

  • 10. Serum levels of 3alpha-androstanediol glucuronide in hirsute and non hirsute women.
    Falsetti L, Rosina B, De Fusco D.
    Eur J Endocrinol; 1998 Apr; 138(4):421-4. PubMed ID: 9578510
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of cyproterone acetate plus ethinylestradiol low dose on plasma androgens and lipids in mildly hirsute or acneic young women.
    Vermeulen A, Rubens R.
    Contraception; 1988 Oct; 38(4):419-28. PubMed ID: 2974791
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
    Lobo RA, Goebelsmann U, Horton R.
    J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
    [Abstract] [Full Text] [Related]

  • 15. Androgen levels during cyproterone acetate and ethinyl oestradiol treatment of hirsutism.
    Rubens R.
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):313-25. PubMed ID: 6233049
    [Abstract] [Full Text] [Related]

  • 16. Time-dependent changes in serum 3 alpha-androstanediol glucuronide correlate with hirsutism scores after ovarian suppression.
    Carmina E, Stanczyk FZ, Gentzchein E, Lobo RA.
    Gynecol Endocrinol; 1995 Sep; 9(3):215-20. PubMed ID: 8540291
    [Abstract] [Full Text] [Related]

  • 17. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
    Falsetti L, Galbignani E.
    Contraception; 1990 Dec; 42(6):611-9. PubMed ID: 2150631
    [Abstract] [Full Text] [Related]

  • 18. 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
    Horton R, Hawks D, Lobo R.
    J Clin Invest; 1982 May; 69(5):1203-6. PubMed ID: 7068855
    [Abstract] [Full Text] [Related]

  • 19. Androsterone glucuronide is a marker of adrenal hyperandrogenism in hirsute women.
    Thompson DL, Horton N, Rittmaster RS.
    Clin Endocrinol (Oxf); 1990 Mar; 32(3):283-92. PubMed ID: 2160872
    [Abstract] [Full Text] [Related]

  • 20. Serum androstanediol glucuronide concentrations in normal and hirsute women and patients with thyroid dysfunction.
    Scanlon MJ, Whorwood CB, Franks S, Reed MJ, James VH.
    Clin Endocrinol (Oxf); 1988 Nov; 29(5):529-38. PubMed ID: 3253032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.